CXCL10

C-X-C motif chemokine ligand 10 P02778 CXL10_HUMAN
Protein Coding Chr 4 4q21.1 Swiss-Prot reviewed Entrez 3627
Mutations
62
CL 9 · Tissue 53
Samples
59
CL 9 · Tissue 50
Peptides
35
unique mutant peptides
Transcripts
1
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations62953
Samples59950
Peptides35531

Function

CXCL10 · C-X-C motif chemokine ligand 10

This antimicrobial gene encodes a chemokine of the CXC subfamily and ligand for the receptor CXCR3. Binding of this protein to CXCR3 results in pleiotropic effects, including stimulation of monocytes, natural killer and T-cell migration, and modulation of adhesion molecule expression. This gene may also be a key regulator of the 'cytokine storm' immune response to SARS-CoV-2 infection. [provided by RefSeq, Sep 2020].

Isoforms & Proteins

1 transcript · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000306602 P02778 62 35

Gene Properties

Type
Protein Coding
Chromosome
4
Cytoband
4q21.1
Entrez ID
Aliases
C7IFI10INP10IP-10SCYB10crg-2

Recurrent Mutations

All 35 amino-acid changes on canonical ENST00000306602 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in CXCL10 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in CXCL10 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
Gastrointestinal Stromal Tumour
0/0 0%
1/133 1%
Endometrial Carcinoma
0/42 0%
4/612 1%
Burkitts Lymphoma
0/32 0%
1/196 1%
Other Blood Cancers
0/61 0%
10/2725 0%
Colorectal Carcinoma
5/143 4%
6/3239 0%
Non-Small Cell Lung Carcinoma
2/304 1%
3/1390 0%
Neuroendocrine Tumour
0/154 0%
2/577 0%
Small Cell Lung Carcinoma
0/9 0%
2/752 0%
Melanoma
0/210 0%
5/1899 0%
Bladder Carcinoma
0/58 0%
2/956 0%
Other Solid Cancers
0/94 0%
3/1515 0%
Esophageal Squamous Cell Carcinoma
0/51 0%
5/2550 0%
Glioma
2/52 4%
1/2127 0%
Head and Neck Carcinoma
0/85 0%
2/1574 0%
Biliary Tract Carcinoma
0/54 0%
1/950 0%
Gastric Carcinoma
0/74 0%
1/1809 0%
Breast Carcinoma
0/144 0%
1/3264 0%

Mutation Distribution

Where CXCL10 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in CXCL10 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 53 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 62 mutations in CXCL10

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide